Patents for A61P 35 - Antineoplastic agents (221,099)
08/1995
08/29/1995US5446036 13-alkyl-11beta-phenylgonanes
08/29/1995US5446035 Stabilize blood calcium and phosphate levels, induce cell differentiation
08/29/1995US5446034 Vitamin D analogues
08/29/1995US5446033 Stabilized hexadecylphosphocholine solutions in glycerol alkyl ethers
08/29/1995CA1336825C Use and agent for reducing the side effects of tnf
08/29/1995CA1336817C Angiogenesis inhibitor
08/29/1995CA1336810C Synergistic interplay of lymphokines and double stranded rnas
08/24/1995WO1995022618A1 Nucleic acid delivery system, method of synthesis and uses thereof
08/24/1995WO1995022617A1 Host-vector system for use in gene therapy
08/24/1995WO1995022550A1 Novel cytotoxic macrolides, their isolation from a marine sponge and their use as antitumor agents
08/24/1995WO1995022549A1 Water-soluble camptothecin derivatives, process for their preparation and their use as antitumor agents
08/24/1995WO1995022546A1 Intracellular signalling mediators
08/24/1995WO1995022541A1 Enantiomerically pure(-)-liarozole
08/24/1995WO1995022540A1 Enantiomerically pure (+)-liarozole
08/24/1995WO1995022538A1 5-substituted derivatives of mycophenolic acid
08/24/1995WO1995022536A1 6-substituted mycophenolic and derivatives with immunosuppressive activity
08/24/1995WO1995022535A1 4-amino derivatives of mycophenolic acid with immunosuppressant activity
08/24/1995WO1995022534A1 4-amino 6-substituted mycophenolic acid and derivatives with immunosuppressive activity
08/24/1995WO1995022524A1 Novel indole derivatives useful to treat estrogen-related neoplasms and disorders
08/24/1995WO1995022349A1 Verotoxin pharmaceutical compositions and medical treatments therewith
08/24/1995WO1995022346A1 Use of ceruletide diethyl amine salt in the treatment of psoriasis
08/24/1995WO1995022341A1 Labelled peptide compounds
08/24/1995CA2183667A1 Nucleic acid delivery system, method of synthesis and uses thereof
08/24/1995CA2183562A1 Intracellular signalling mediators
08/24/1995CA2183533A1 6-substituted mycophenolic acid and derivatives
08/24/1995CA2183532A1 4-amino 6-substituted mycophenolic acid and derivatives
08/24/1995CA2183530A1 5-substituted derivatives of mycophenolic acid
08/24/1995CA2183529A1 4-amino derivatives of mycophenolic acid
08/24/1995CA2183421A1 Labelled peptide compounds
08/24/1995CA2182583A1 Enantiomerically pure (+)-liarozole
08/24/1995CA2160251A1 Use of ceruletide diethyl amine salt in the treatment of psoriasis
08/23/1995EP0668350A1 Melanoma associated antigenic polypeptide, epitopes thereof and vaccines against melanoma
08/23/1995EP0668281A1 Acronycin analogues, process for their preparation and pharmaceutical compositions containing them
08/23/1995EP0668278A1 Adhesion receptor antagonists
08/23/1995EP0668074A1 Pharmaceutical composition
08/23/1995EP0667922A1 Process for the preparation of taxane derivatives, novel taxanes so obtained and antitumour and antileukaemia compositions containing same
08/23/1995EP0667912A1 Defective adenovirus vectors and use thereof in gene therapy
08/23/1995EP0667787A1 Group b streptococcus type ii and type v polysaccharide-protein conjugate vaccines
08/23/1995EP0667775A1 Methods and compositions of (+) doxazosin for the treatment of benign prostatic hyperplasia and atherosclerosis
08/23/1995EP0667772A1 Taxanes having an alkyl substituted side-chain and pharmaceutical compositions containing them
08/23/1995EP0667771A1 Antitumour compositions containing taxane derivatives
08/23/1995EP0667770A1 Inhibition of tnf production.
08/23/1995EP0500653A4 Inhibitors of purine nucleoside phosphorylase
08/23/1995CN1107159A Linear adhesion inhibitors
08/23/1995CN1107067A Tianjianwan and producing technology
08/23/1995CN1107040A Medicine bar for fumigation
08/22/1995US5444153 Plasminogen activator inhibitor which has been altered to eliminate a protease sensitive site
08/22/1995US5444089 Neutral lipids from endosperm of Job's tears
08/22/1995US5444072 Useful in treatment of autoimmune disorders, psoriasis, inflammatory diseases, rheumatoid arthritis
08/22/1995US5444062 Quinazolines derivatives for enhancing antitumor activity
08/22/1995US5444061 Antitumor agents
08/22/1995US5444050 Binding of E-selectin or P-selectin to sialyl Lewisx or sialyl-Lewisa
08/22/1995US5443967 DNA encoding the cancer associated SCM recognition factor
08/22/1995US5443825 A polypeptide sequence as anticarcinogenic agent, suppressors; cytolysis
08/22/1995CA2012013C Antitumor antibiotic bmy-41339
08/22/1995CA1336760C Antibody-mediated and ligand-mediated targeting of differentiation-inducers to tumor cells
08/20/1995CA2142741A1 Adhesion receptor antagonists
08/19/1995CA2142315A1 Drug
08/17/1995WO1995021927A2 Targeting gene therapy
08/17/1995WO1995021917A1 Mammalian cell cycle protein
08/17/1995WO1995021866A1 An immunointeractive molecule which binds the tie2/tek receptor extracellular domain
08/17/1995WO1995021865A1 Immunointeractive molecules-i
08/17/1995WO1995021845A1 Texaphyrin metal complexes having improved functionalization
08/17/1995WO1995021819A1 Aralkoxy and aralkylthio substituted azacyclic compounds as tachykinin antagonists
08/17/1995WO1995021630A1 Methods for identifying individuals suffering from a cellular abnormality
08/17/1995WO1995021613A1 Compounds for the treatment of disorders related to vasculogenesis and/or angiogenesis
08/17/1995WO1995021610A1 Use of derivatives of 2,4-bisubstituted phenols as 5-lipoxigenase inhibitors
08/17/1995WO1995007994A3 Recombinant alphavirus vectors
08/17/1995CA2183254A1 Mammalian cell cycle protein
08/17/1995CA2182969A1 Methods for identifying individuals suffering from a cellular abnormality
08/17/1995CA2182960A1 Texaphyrin metal complexes having improved functionalization
08/17/1995CA2182734A1 Aralkoxy and aralkylthio substituted azacyclic compounds as tachykinin antagonists
08/17/1995CA2182682A1 Immunointeractive molecules-i
08/17/1995CA2182681A1 An immunointeractive molecule which binds the tie2/tek receptor extracellular domain
08/17/1995CA2141506A1 Cosmetic or pharmaceutical compositions containing liposomes
08/16/1995EP0667351A1 Compound uch9
08/16/1995EP0667165A1 Therapeutic compositions containing monoclonal antibodies specific to human epidermal growth factor receptor
08/16/1995EP0667154A1 Use of flavolignans as adjuvants in the therapy of tumors
08/16/1995EP0666929A1 Method of inhibiting replication of hyperproliferative cells
08/16/1995EP0666914A1 Novel p-selectin ligand protein
08/16/1995EP0666868A1 Vascular endothelial cell growth factor antagonists
08/16/1995EP0666859A1 Wavelength-specific photosensitive porphacyanine and expanded porphyrin-like compounds and methods for preparation and use thereof
08/16/1995EP0666857A1 Method for preparing taxane derivatives
08/16/1995EP0666856A1 4-arylmethyloxymethyl piperidines as tachykinin antagonists
08/16/1995EP0666845A1 High purity beta-carotene
08/16/1995EP0666844A1 Inhibitors of farnesyl-protein transferase
08/16/1995EP0666761A1 Stimulation of an antitumor t-cell response using anti-idiotypic antibodies
08/16/1995EP0666757A1 Anti-inflammatory, tolerogenic and immunostimulatory properties of carbohydrate binding-proteins
08/16/1995EP0666742A1 Adenosine diphosphoribose polymerase binding nitroso aromatic compounds useful as anti-retroviral agents and anti-tumor agents
08/16/1995EP0666738A1 Inhibitors of farnesyl-protein transferase
08/16/1995EP0655920A4 Astragalus polysaccharide immunomodulators.
08/16/1995EP0655913A4 Novel metallocenes as anti-tumor drugs.
08/16/1995EP0532525B1 New protein-polycation conjugates
08/16/1995CN1106806A Adhesion receptor antagonists
08/16/1995CN1106666A Pharmaceutical use of 24-homo-vitamin-D-derivative
08/15/1995US5442102 Antitumor agents
08/15/1995US5442064 Anticoagulants, antiagglomerants
08/15/1995US5441986 Estrogen agonists as remedies for prostate and cardiovascular diseases
08/15/1995US5441976 Immunostimulants
08/15/1995US5441953 4- amino derivatives of mycophenolic acid